1. Home
  2. CSGP vs ARGX Comparison

CSGP vs ARGX Comparison

Compare CSGP & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSGP
  • ARGX
  • Stock Information
  • Founded
  • CSGP 1987
  • ARGX 2008
  • Country
  • CSGP United States
  • ARGX Netherlands
  • Employees
  • CSGP N/A
  • ARGX N/A
  • Industry
  • CSGP Business Services
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CSGP Consumer Discretionary
  • ARGX Health Care
  • Exchange
  • CSGP Nasdaq
  • ARGX Nasdaq
  • Market Cap
  • CSGP 32.2B
  • ARGX 37.3B
  • IPO Year
  • CSGP 1998
  • ARGX 2017
  • Fundamental
  • Price
  • CSGP $72.28
  • ARGX $627.40
  • Analyst Decision
  • CSGP Buy
  • ARGX Strong Buy
  • Analyst Count
  • CSGP 13
  • ARGX 20
  • Target Price
  • CSGP $93.00
  • ARGX $634.50
  • AVG Volume (30 Days)
  • CSGP 2.4M
  • ARGX 257.3K
  • Earning Date
  • CSGP 02-18-2025
  • ARGX 10-31-2024
  • Dividend Yield
  • CSGP N/A
  • ARGX N/A
  • EPS Growth
  • CSGP N/A
  • ARGX N/A
  • EPS
  • CSGP 0.43
  • ARGX N/A
  • Revenue
  • CSGP $2,666,900,000.00
  • ARGX $1,908,659,000.00
  • Revenue This Year
  • CSGP $13.48
  • ARGX $61.99
  • Revenue Next Year
  • CSGP $12.85
  • ARGX $42.48
  • P/E Ratio
  • CSGP $170.02
  • ARGX N/A
  • Revenue Growth
  • CSGP 11.67
  • ARGX 85.56
  • 52 Week Low
  • CSGP $68.26
  • ARGX $349.86
  • 52 Week High
  • CSGP $100.38
  • ARGX $644.97
  • Technical
  • Relative Strength Index (RSI)
  • CSGP 42.57
  • ARGX 61.06
  • Support Level
  • CSGP $71.80
  • ARGX $623.78
  • Resistance Level
  • CSGP $73.52
  • ARGX $637.08
  • Average True Range (ATR)
  • CSGP 2.22
  • ARGX 13.21
  • MACD
  • CSGP -0.38
  • ARGX -0.35
  • Stochastic Oscillator
  • CSGP 32.11
  • ARGX 67.96

About CSGP CoStar Group Inc.

CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

Share on Social Networks: